WallStreetZenWallStreetZen

NASDAQ: ALMR
Alamar Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ALMR

Based on 4 analysts offering 12 month price targets for Alamar Biosciences Inc

Min Forecast
$30.00-2.6%
Avg Forecast
$33.00+7.14%
Max Forecast
$35.00+13.64%

Should I buy or sell ALMR stock?

Based on 4 analysts offering ratings for Alamar Biosciences Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ALMR's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ALMR as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ALMR stock forecasts and price targets.

ALMR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-11Find Out Why
lockedlocked$00.00+00.00%2026-08-11
lockedlocked$00.00+00.00%2026-05-12
lockedlocked$00.00+00.00%2026-05-12

1 of 1

Forecast return on equity

Is ALMR forecast to generate an efficient return?

Company
-1.21%
Industry
22.89%
Market
167.6%
ALMR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALMR forecast to generate an efficient return on assets?

Company
-0.97%
Industry
13.71%
ALMR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALMR earnings per share forecast

What is ALMR's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.24
Avg 2 year Forecast
-$0.68
Avg 3 year Forecast
-$0.39

ALMR revenue forecast

What is ALMR's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$121.0M
Avg 2 year Forecast
$169.0M
Avg 3 year Forecast
$228.6M

ALMR vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ALMR$30.80$33.00+7.14%Strong Buy
NVCR$17.94$25.20+40.47%Hold
ESTA$74.29$101.17+36.18%Strong Buy
UFPT$288.79N/AN/A
BFLY$7.36N/AN/A
View Top Medical Device Stocks

Alamar Biosciences Stock Forecast FAQ

Is Alamar Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: ALMR) stock is to Strong Buy ALMR stock.

Out of 4 analysts, 3 (75%) are recommending ALMR as a Strong Buy, 1 (25%) are recommending ALMR as a Buy, 0 (0%) are recommending ALMR as a Hold, 0 (0%) are recommending ALMR as a Sell, and 0 (0%) are recommending ALMR as a Strong Sell.

If you're new to stock investing, here's how to buy Alamar Biosciences stock.

What is ALMR's earnings growth forecast for 2026-2028?

(NASDAQ: ALMR) Alamar Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.07%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.05%.

Alamar Biosciences's earnings in 2026 is N/A.On average, 7 Wall Street analysts forecast ALMR's earnings for 2026 to be -$86,213,572, with the lowest ALMR earnings forecast at -$89,086,433, and the highest ALMR earnings forecast at -$80,148,645. On average, 7 Wall Street analysts forecast ALMR's earnings for 2027 to be -$47,138,506, with the lowest ALMR earnings forecast at -$61,204,420, and the highest ALMR earnings forecast at -$37,888,450.

In 2028, ALMR is forecast to generate -$26,896,636 in earnings, with the lowest earnings forecast at -$44,203,192 and the highest earnings forecast at $0.

What is ALMR's revenue growth forecast for 2026-2028?

(NASDAQ: ALMR) Alamar Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.43%.

Alamar Biosciences's revenue in 2026 is N/A.On average, 7 Wall Street analysts forecast ALMR's revenue for 2026 to be $8,397,218,614, with the lowest ALMR revenue forecast at $8,010,700,907, and the highest ALMR revenue forecast at $8,696,995,363. On average, 7 Wall Street analysts forecast ALMR's revenue for 2027 to be $11,723,907,816, with the lowest ALMR revenue forecast at $10,703,834,156, and the highest ALMR revenue forecast at $12,539,966,744.

In 2028, ALMR is forecast to generate $15,860,410,597 in revenue, with the lowest revenue forecast at $14,240,089,511 and the highest revenue forecast at $17,379,418,245.

What is ALMR's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ALMR) forecast ROA is -0.97%, which is lower than the forecast US Medical Devices industry average of 13.71%.

What is ALMR's Price Target?

According to 4 Wall Street analysts that have issued a 1 year ALMR price target, the average ALMR price target is $33.00, with the highest ALMR stock price forecast at $35.00 and the lowest ALMR stock price forecast at $30.00.

On average, Wall Street analysts predict that Alamar Biosciences's share price could reach $33.00 by Aug 11, 2027. The average Alamar Biosciences stock price prediction forecasts a potential upside of 7.14% from the current ALMR share price of $30.80.

What is ALMR's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ALMR) Alamar Biosciences's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that ALMR's EPS will be -$1.24 for 2026, with the lowest EPS forecast at -$1.28, and the highest EPS forecast at -$1.16. On average, analysts forecast that ALMR's EPS will be -$0.68 for 2027, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.55. In 2028, ALMR's EPS is forecast to hit -$0.39 (min: -$0.64, max: $0.00).

What is ALMR's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ALMR) forecast ROE is -1.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.